8-K: DHC Boosts Outlook, Deleveraging Amid Strategic Shifts

Diversified Healthcare Trust provides an investor update detailing Q2 2025 financial results, strategic SHOP portfolio initiatives, and capital recycling plans.

Summary

• Total revenues for Q2 2025 were $382.7 million.
• A net loss of $91.6 million, or $0.38 per share, was reported for Q2 2025.
• Normalized FFO for Q2 2025 was $18.6 million, or $0.08 per share.
• Same property Cash Basis NOI increased by $7.2 million, or 11.2%, year-over-year to $71.2 million in Q2 2025.
• SHOP same property NOI increased 18.5% year-over-year, driven by a 100 bps increase in occupancy and a 5.2% increase in average monthly rate.
• The Medical Office and Life Science Portfolio executed approximately 106,000 square feet of leasing activity at weighted average rents 11.5% higher than prior rents.
• 2025 guidance includes total NOI of $265 million to $285 million, SHOP CapEx of $115 million to $125 million, and total CapEx of $140 million to $160 million.
• Year-end SHOP occupancy is projected to grow to 82% 83%.
• Estimated disposition proceeds for 2025 are $625 million to $635 million, with $369 million completed YTD as of October 3, 2025, and $264 million under agreements or letters of intent.
• A strategic transaction with AlerisLife Inc. involves selling management agreements for 116 SHOP communities and transitioning management to seven new operators, with estimated net proceeds to DHC of $25 million to $40 million.
• Leverage improved from 11.2x in 4Q24 to 8.7x in 2Q25.
• Moodys and S&P Global upgraded DHC to Caa1 and B-, respectively, in 3Q25.
• Management is initially targeting leverage of 6.5x to 7.5x.

Sentiment

Score: 7

Explanation: The filing presents strong operational improvements in the SHOP segment, significant deleveraging, and positive guidance adjustments, alongside favorable industry tailwinds. While a net loss was reported, the underlying operational metrics and strategic execution are positive, indicating a strong path to recovery and growth.

Positives

• Same property Cash Basis NOI increased by 11.2% year-over-year to $71.2 million in Q2 2025.
• SHOP same property NOI increased 18.5% year-over-year, reflecting a 100 bps increase in occupancy and a 5.2% increase in average monthly rate.
• SHOP margin improved by 180 bps in Q2 2025 compared to Q2 2024.
• Executed approximately 106,000 square feet of leasing activity within the Medical Office and Life Science Portfolio at weighted average rents 11.5% higher than prior rents.
• Increased 2025 SHOP NOI outlook by $10 million at the midpoint and decreased total CapEx by $10 million.
• Completed $369 million in asset dispositions YTD as of October 3, 2025, with an additional $264 million under agreements or letters of intent.
• Raised over $1.2 billion from diversified funding sources YTD 2025, highlighting ability to tap into multiple markets.
• Improved leverage from 11.2x in 4Q24 to 8.7x in 2Q25.
• Moodys and S&P Global upgraded DHC to Caa1 and B-, respectively, in 3Q25.
• Successful SHOP renovations, such as Barrington Terrace at Boynton Beach, FL, achieved a 128.6% total project ROI, 29.5% RevPOR growth, and 5.0 percentage points occupancy growth.
• Favorable senior living industry trends include an 80+ population projected to grow at a 4.0% CAGR over 15 years, while inventory growth is expected to remain depressed at 1.0%.
• The Medical Office Portfolio is well positioned to capitalize on growth opportunities due to growing demand for healthcare services and a shift towards outpatient care.
• The Life Science sector is maintaining fundamentals with long-term growth drivers intact, including rising chronic disease prevalence and high R&D spending.

Negatives

• Reported a net loss of $91.6 million, or $0.38 per share, for Q2 2025.
• 26 SHOP properties under agreements or letters of intent for sale had a negative NOI of $(0.6) million for the three months ended June 30, 2025.
• Life science sector absorption has not yet taken hold despite the end of the new construction pipeline.

Risks

• Impact of unfavorable market and commercial real estate industry conditions due to reduced demand for healthcare related space and senior living communities, uncertainties surrounding interest rates, wage and commodity price inflation, supply chain disruptions, volatility in public debt and equity markets, effects of tariffs or trading policies, pandemics, geopolitical instability, economic uncertainties, labor market conditions, or changes in real estate utilization.
• Senior living operators' abilities to successfully and profitably operate the communities they manage.
• The continuing impact of changing market practices on DHC and its managers and other operators and tenants, such as delayed recovery of the senior living industry, reduced demand for leased medical office, life science, and other space, and increased operating costs.
• The financial strength of DHC's managers and other operators and tenants.
• Whether the aging U.S. population and increasing life spans of seniors will increase the demand for senior living communities and other medical and healthcare related properties and services.
• Whether DHC's tenants will renew or extend their leases or whether DHC will obtain replacement tenants on terms as favorable as prior leases.
• The likelihood that DHC's tenants and residents will pay rent or be negatively impacted by continuing unfavorable market and commercial real estate industry conditions.
• DHC's managers' abilities to increase or maintain rates charged to residents and manage operating costs for senior living communities.
• DHC's ability to increase or maintain occupancy at its properties on terms desirable to DHC and to increase rents when leases expire or renew.
• Costs DHC incurs and concessions it grants to lease its properties.
• Risks and uncertainties regarding the costs and timing of development, redevelopment, and repositioning activities, including as a result of inflation, cost overruns, supply chain challenges, labor shortages, construction delays, or inability to obtain necessary permits or volatility in commercial real estate markets.
• DHC's ability to manage its capital expenditures and other operating costs effectively and to maintain and enhance its properties and their appeal to tenants and residents.
• DHC's ability to effectively raise and balance its use of debt and equity capital and to purchase cost-effective interest rate caps.
• DHC's ability to comply with the financial covenants under its debt agreements and to make required payments on its debt.
• DHC's ability to maintain sufficient liquidity, including the availability of borrowings under its revolving credit facility, and otherwise manage leverage.
• DHC's credit ratings.
• DHC's ability to sell properties at prices or returns it targets, and the timing of such sales.
• DHC's ability to sell additional equity interests in, or contribute additional properties to, its existing joint ventures, or enter into additional real estate joint ventures or to attract co-venturers and benefit from existing or future joint ventures.
• DHC's ability to acquire, develop, redevelop, or reposition properties that realize its targeted returns.
• Non-performance by counterparties to DHC's interest rate caps.
• DHC's ability to pay distributions to its shareholders and to maintain or increase the amount of such distributions.
• The ability of The RMR Group LLC (RMR) to successfully manage DHC.
• Competition in the real estate industry, particularly in those markets where DHC's properties are located.
• Government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements.
• Compliance with, and changes to, federal, state, and local laws and regulations, accounting rules, tax laws, and similar matters.
• Exposure to litigation and regulatory and government proceedings due to the nature of the senior living and other health and wellness related service businesses.
• Actual and potential conflicts of interest with DHC's related parties, including DHC's Managing Trustees, RMR, ABP Trust, AlerisLife Inc., and others affiliated with them.
• Limitations imposed by and DHC's ability to satisfy complex rules to maintain its qualification for taxation as a real estate investment trust (REIT) for U.S. federal income tax purposes.
• Acts of terrorism, outbreaks of pandemics or other public health safety events or conditions, war or other hostilities, global climate change, or other manmade or natural disasters beyond DHC's control.

Future Outlook

Year-end SHOP occupancy is projected to grow to 82% 83%. The 2025 SHOP NOI outlook has been increased by $10 million at the midpoint, while total CapEx has been decreased by $10 million. Estimated disposition proceeds for 2025 are $625 million to $635 million. Management is initially targeting leverage of 6.5x to 7.5x to further enhance its cost of capital and improve its outlook with rating agencies. SHOP margin expansion is expected to continue, driven by revenue growth and expense management. Favorable senior living industry trends, including an aging 80+ population growing at a 4.0% CAGR and depressed inventory growth at 1.0%, are expected to support operational momentum. The Medical Office Portfolio is well positioned to capitalize on growth opportunities due to growing demand for healthcare services, a shift towards outpatient care, and limited new supply. The Life Science sector is expected to maintain fundamentals with long-term growth drivers intact, including rising chronic disease prevalence and high R&D spending.

Management Comments

• DHC is conducting top-to-bottom portfolio analyses to optimize occupancy growth and margin expansion.
• DHC is focused on driving revenue growth coupled with expense management.
• DHC has consistently proven its ability to deliver on key strategic priorities, such as executing on 11 asset dispositions and new financings with an emphasis on reducing the company's leverage and cost of capital.
• Management is focused on clustering communities to drive operational synergies.

Industry Context

The senior living industry is experiencing strong tailwinds with the 80+ population projected to grow at a 4.0% CAGR over the next 15 years, significantly outpacing the expected 1.0% inventory growth. This favorable supply/demand dynamic supports DHC's strategy for occupancy and rate growth in its SHOP segment. The medical office market is benefiting from an aging population, increased healthcare spending, and a pronounced shift towards outpatient care, which drives demand for DHC's predominantly outpatient facilities. Limited new construction due to rising costs further strengthens the market for existing assets. The life science sector, despite some recent uncertainties, maintains robust long-term growth drivers, including rising chronic disease prevalence and high R&D spending, aligning with DHC's life science portfolio concentration in leading research markets.

Comparison to Industry Standards

• SHOP RevPOR increased 5.4% year-over-year, outpacing the respective NIC markets' average increase of 4.2% year-over-year.
• AlerisLife transition communities show occupancy upside potential compared to NIC benchmark data; for example, Sinceri Senior Living's pro forma 2Q25 occupancy of 78.0% is below the NIC benchmark of 83.5%, indicating room for growth.
• Outpatient visits per 1,000 people grew 31% from 2000 to 2023, while hospital inpatient admissions per 1,000 declined 19%, demonstrating a significant industry shift towards outpatient care that DHC's medical office portfolio is well-positioned to capitalize on.

Corporate Governance

Related Party Transactions

• Strategic transaction with AlerisLife Inc. to sell its management agreements for 116 DHC communities and transition management to new operators. AlerisLife is selling all its assets and winding down its business.
• DHC's return on investment in AlerisLife is calculated based on a $15.5 million investment to reacquire a 34% ownership stake in 1Q24, a $17.0 million 1Q25 dividend payment, a $3.4 million 2Q25 dividend payment, and $25.0 million $40.0 million in estimated proceeds from this transaction.
• DHC is managed by The RMR Group LLC, an alternative asset manager, with management fees and incentive fees structured to align with shareholder interests, including RMR senior management holding DHC shares.

Stakeholder Impact

• Shareholders: Potential for increased value through improved operational performance, deleveraging, strategic dispositions, and credit rating upgrades. The AlerisLife transaction is expected to yield $25M-$40M in net proceeds.
• Residents/Tenants: Enhanced care plans, renovated facilities, and improved operational efficiencies in senior living communities. Medical office and life science tenants benefit from high-quality, strategically located properties.
• Employees (of operators): Management transitions to new operators for 116 SHOP communities may impact employees of AlerisLife, but new operators are taking over.
• Creditors: Improved leverage ratios (from 11.2x to 8.7x) and credit rating upgrades (Moodys Caa1, S&P B-) enhance DHC's creditworthiness and reduce risk.

Next Steps

• Complete the transition of AlerisLife management agreements for 116 DHC communities by year-end 2025.
• Execute on capital recycling plans, including the sale of 47 properties under agreements or letters of intent for expected gross proceeds of $264 million.
• Work towards an initial target leverage of 6.5x to 7.5x to further enhance cost of capital and improve outlook with rating agencies.
• Repay $334.4 million in 2026 Senior Secured Notes.
• Continue to implement standard operating procedures, performance tracking, revenue management, and expense control initiatives in the SHOP portfolio.
• Further invest in strategic ROI capital opportunities to drive NOI growth.

Key Dates

Recommendation

Diversified Healthcare Trust demonstrates strong operational improvements in its SHOP portfolio, significant deleveraging, and positive adjustments to its 2025 guidance, including increased NOI outlook and reduced CapEx. The strategic disposition program and the AlerisLife transaction are expected to further enhance the portfolio and liquidity. Credit rating upgrades from Moodys and S&P Global are positive signals. However, the company still reported a net loss in Q2 2025, and while leverage has improved, the target range of 6.5x to 7.5x indicates further work is needed. Given the positive momentum and strategic execution, but also the remaining challenges, a 'hold' recommendation is appropriate for investors to observe continued progress towards financial stability and leverage targets.

Keywords

Healthcare REIT, Senior Living, Medical Office, Life Science, Real Estate, DHC, Diversified Healthcare Trust, REIT, Property Dispositions, Occupancy Growth, NOI Growth, Capital Recycling, AlerisLife, Debt Reduction, Credit Rating Upgrade